Gastroesophageal Reflux Disease Tied to Increased Risk for Rheumatoid Arthritis
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Aug. 14, 2024 -- Gastroesophageal reflux disease (GERD) increases the risk for rheumatoid arthritis (RA), according to a study published online Aug. 1 in Scientific Reports.
Quan Yuan, from the First Hospital of Jilin University in Changchun, China, and colleagues used Mendelian randomization (MR) to assess the causal relationship between GERD and RA.
The researchers found that MR results suggest a causal effect of the genetic susceptibility of GERD on RA (discovery dataset, inverse variance weighting, odds ratio, 1.41; validation dataset, inverse variance weighting, odds ratio, 1.38). When adjusting for confounding factors between GERD and RA, including smoking quantity, drinking frequency, body mass index, depression, and education attainment, MR analysis results were similar. However, the reverse MR analysis did not show evidence that RA can increase the risk for developing GERD.
"This finding is crucial for deepening our understanding of the pathogenesis of RA and may offer new insights for the prevention and treatment of RA," the authors write. "It also offers a new perspective on preventing the occurrence of GERD in patients with RA. However, based on the results of the reverse MR analysis using the existing dataset, compelling evidence was not found for RA increasing the risk of developing GERD."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-08-15 01:15
Read more
- Incidence of Dyslipidemia Elevated During COVID-19 Pandemic
- Doctors Report First U.S. Cases of Sexually Transmitted Ringworm Rash
- Dizal Submits New Drug Application to the U.S. FDA for Sunvozertinib in Treating Relapsed or Refractory Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
- USPSTF Recommends Early Screening for Syphilis in Pregnancy
- Transcranial Direct Current Stimulation Safe, Effective for Tardive Dyskinesia
- Anxiety/Depression Linked to HRQoL Losses in Seropositive RA
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions